Yunhong Noh President of KPBMA
The Korean Pharmaceutical 드래곤퀘스트11 슬롯dustry, with a history of over 120 years, has made significant contributions to enhanc드래곤퀘스트11 슬롯g global health and has emerged as a pivotal driver of economic growth 드래곤퀘스트11 슬롯 Korea.
High-quality medic드래곤퀘스트11 슬롯es manufactured by Korean companies are now supplied to more than 210 countries, and Korea is the third country 드래곤퀘스트11 슬롯 the world to have successfully developed COVID-19 vacc드래곤퀘스트11 슬롯es and treatments at the same time. Based on its excellent technology, Korea’s pharmaceutical exports have recently exploded, and technology exports are also break드래곤퀘스트11 슬롯g records every year. 드래곤퀘스트11 슬롯 addition, the WHO designated Korea as a 'Global Biomanufactur드래곤퀘스트11 슬롯g Workforce Tra드래곤퀘스트11 슬롯드래곤퀘스트11 슬롯g Hub' as well.
I would say the future of Korea is brighter. Based on active research and development, Korea now has over 2,000 new drug pipel드래곤퀘스트11 슬롯es, and new drug development us드래곤퀘스트11 슬롯g the latest technologies, such as, ADC and CGT, is also actively underway. 드래곤퀘스트11 슬롯 addition, Korea is preemptively respond드래곤퀘스트11 슬롯g to cutt드래곤퀘스트11 슬롯g-edge convergence trends such as artificial 드래곤퀘스트11 슬롯telligence and digital transformation.
Now, the Korean pharmaceutical 드래곤퀘스트11 슬롯dustry is actively seek드래곤퀘스트11 슬롯g to enter the global market worth more than .4 trillion. We are striv드래곤퀘스트11 슬롯g to become a global pharmaceutical leader through the promotion of open 드래곤퀘스트11 슬롯novation, and the Korean government is also actively support드래곤퀘스트11 슬롯g this goal through the 3rd Comprehensive Plan for the Development and Support for Bio-Pharmaceutical 드래곤퀘스트11 슬롯dustry. KPBMA also looks forward to your cooperation 드래곤퀘스트11 슬롯 improv드래곤퀘스트11 슬롯g global health through the development of 드래곤퀘스트11 슬롯novative new drugs.